Effect of Farnesyltransferase Inhibitor R115777 on Mitochondria of Plasmodium falciparum
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
The parasite Plasmodium falciparum causes severe malaria and is the most dangerous to humans. However, it exhibits resistance to their drugs. Farnesyltransferase has been identified in pathogenic protozoa of the genera Plasmodium and the target of farnesyltransferase includes Ras family. Therefore, the inhibition of farnesyltransferase has been suggested as a new strategy for the treatment of malaria. However, the exact functional mechanism of this agent is still unknown. In addition, the effect of farnesyltransferase inhibitor (FTIs) on mitochondrial level of malaria parasites is not fully understood. In this study, therefore, the effect of a FTI R115777 on the function of mitochondria of P. falciparum was investigated experimentally. As a result, FTI R115777 was found to suppress the infection rate of malaria parasites under in vitro condition. It also reduces the copy number of mtDNA-encoded cytochrome c oxidase III. In addition, the mitochondrial membrane potential (ΔΨm) and the green fluorescence intensity of MitoTracker were decreased by FTI R115777. Chloroquine and atovaquone were measured by the mtDNA copy number as mitochondrial non-specific or specific inhibitor, respectively. Chloroquine did not affect the copy number of mtDNA-encoded cytochrome c oxidase III, while atovaquone induced to change the mtDNA copy number. These results suggest that FTI R115777 has strong influence on the mitochondrial function of P. falciparum. It may have therapeutic potential for malaria by targeting the mitochondria of parasites.
Abstract
The parasite Plasmodium falciparum causes severe malaria and is the most dangerous to humans. However, it exhibits resistance to their drugs. Farnesyltransferase has been identified in pathogenic protozoa of the genera Plasmodium and the target of farnesyltransferase includes Ras family. Therefore, the inhibition of farnesyltransferase has been suggested as a new strategy for the treatment of malaria. However, the exact functional mechanism of this agent is still unknown. In addition, the effect of farnesyltransferase inhibitor (FTIs) on mitochondrial level of malaria parasites is not fully understood. In this study, therefore, the effect of a FTI R115777 on the function of mitochondria of P. falciparum was investigated experimentally. As a result, FTI R115777 was found to suppress the infection rate of malaria parasites under in vitro condition. It also reduces the copy number of mtDNA-encoded cytochrome c oxidase III. In addition, the mitochondrial membrane potential (ΔΨm) and the green fluorescence intensity of MitoTracker were decreased by FTI R115777. Chloroquine and atovaquone were measured by the mtDNA copy number as mitochondrial non-specific or specific inhibitor, respectively. Chloroquine did not affect the copy number of mtDNA-encoded cytochrome c oxidase III, while atovaquone induced to change the mtDNA copy number. These results suggest that FTI R115777 has strong influence on the mitochondrial function of P. falciparum. It may have therapeutic potential for malaria by targeting the mitochondria of parasites.
참고문헌 (38)
- Farooq U, "Drug resistance in malaria", J Vector Borne Dis, 41, pp.45~53 (2004)
- Hogg T, "Structural and functional characterization of falcipain-2, a hemoglobinase from the malarial parasite Plasmodium falciparum", J Biol Chem, 281, pp.25425~25437 (2006)
- Sidhu AB, "Chloroquine resistance in Plasmodium falciparum malaria parasites conferred by pfcrt mutations", Science, 298, pp.210~213 (2002)
- Wang J, "Artemisinin directly targets malarial mitochondria through its specific mitochondrial activation", PLoS One, 5, pp.e9582~ (2010)
- Nallan L, "Protein farnesyltransferase inhibitors exhibit potent antimalarial activity", J Med Chem, 48, pp.3704~3713 (2005)
- Vigil D, "Ras superfamily GEFs and GAPs: validated and tractable targets for cancer therapy?", Nat Rev Cancer, 10, pp.842~857 (2010)
- Wiesner J, "Farnesyltransferase inhibitors inhibit the growth of malaria parasites in vitro and in vivo", Angew Chem Int Ed Engl, 43, pp.251~254 (2004)
- Appels NM, "Development of farnesyl transferase inhibitors: a review", Oncologist, 10, pp.565~578 (2005)
- Kohring K, "Development of benzophenone-based farnesyltransferase inhibitors as novel antimalarials", ChemMedChem, 3, pp.1217~1231 (2008)
- Ly JD, "The mitochondrial membrane potential (deltapsi(m)) in apoptosis; an update", Apoptosis, 8, pp.115~128 (2003)
- Vaidya AB, "Mitochondrial evolution and functions in malaria parasites", Annu Rev Microbiol, 63, pp.249~267 (2009)
- Torrentino-Madamet M, "Microaerophilic respiratory metabolism of Plasmodium falciparum mitochondrion as a drug target", Curr Mol Med, 10, pp.29~46 (2010)
- Trager W, "Human malaria parasites in continuous culture", Science, 193, pp.673~675 (1976)
- Lambros C, "Synchronization of Plasmodium falciparum erythrocytic stages in culture", J Parasitol, 65, pp.418~420 (1979)
- Salehnia M, "Does cryopreservation of ovarian tissue affect the distribution and function of germinal vesicle oocytes mitochondria?", Biomed Res Int, 2013, pp.8~ (2013)
- Kellner K, "Determination of oxygen gradients in engineered tissue using a fluorescent sensor", Biotechnol Bioeng, 80, pp.73~83 (2002)
- Othman A, "12", 15-Lipoxygenase-derived lipid metabolites induce retinal endothelial cell barrier dysfunction: contribution of NADPH oxidase, 2013, pp.8, e57254~
- Hamilton ML, "Richardson A. Does oxidative damage to DNA increase with age?", Proc Natl Acad Sci USA, 98, pp.10469~10474 (2001)
- Cunha MG, "Development of a polymerase chain reaction (PCR) method based on amplification of mitochondrial DNA to detect Plasmodium falciparum and Plasmodium vivax", Acta Trop, 111, pp.35~38 (2009)
- Buckling A, "Chloroquine increases Plasmodium falciparum gametocytogenesis in vitro", Parasitology, 118(Part 4), pp.339~346 (1999)
- Painter HJ, "Specific role of mitochondrial electron transport in blood-stage Plasmodium falciparum", Nature, 446, pp.88~91 (2007)
- Narendra DP, "PINK1 is selectively stabilized on impaired mitochondria to activate parkin", PLoS Biol, 8, pp.e1000298~ (2010)
- Chazotte B, "Labeling mitochondria with MitoTracker dyes", Cold Spring Harb Protoc, 2011, pp.990~992 (2011)
- Lancet JE, "A phase 2 study of the farnesyltransferase inhibitor tipifarnib in poor-risk and elderly patients with previously untreated acute myelogenous leukemia", Blood, 109, pp.1387~1394 (2007)
- Zhu KC, "Farnesyltransferase inhibitor R115777 (Zarnestra, Tipifarnib) synergizes with paclitaxel to induce apoptosis and mitotic arrest and to inhibit tumor growth of multiple myeloma cells", Blood, 105, pp.4759~4766 (2005)
- Balabaskaran Nina P, "ATP synthase complex of Plasmodium falciparum: dimeric assembly in mitochondrial membranes and resistance to genetic disruption", J Biol Chem, 286, pp.41312~41322 (2011)
- Kataoka M, "Analysis of mitochondrial membrane potential in the cells by microchip flow cytometry", Electrophoresis, 26, pp.3025~3031 (2005)
- Rousset S, "The biology of mitochondrial uncoupling proteins", Diabetes, 53(suppl 1), pp.S130~S135 (2004)
- Shen J, "Oxygen consumption rates and oxygen concentration in molt-4 cells and their mtDNA depleted (rho0) mutants", Biophys J, 84, pp.1291~1398 (2003)
- Goncalves RL, "Mitochondrial reactive oxygen species modulate mosquito susceptibility to Plasmodium infection", PLoS One, 7, pp.e41083~ (2012)
- Molina-Cruz A, "Reactive oxygen species modulate Anopheles gambiae immunity against bacteria and Plasmodium", J Biol Chem, 283, pp.3217~3223 (2008)
- West AP, "TLR signalling augments macrophage bactericidal activity through mitochondrial ROS", Nature, 472, pp.476~480 (2011)
- Pabon A, "Oxidative stress in patients with non-complicated malaria", Clin Biochem, 36, pp.71~78 (2003)
- Krungkrai J, "Mitochondrial ubiquinol-cytochrome c reductase and cytochrome c oxidase: chemotherapeutic targets in malarial parasites", Biochem Mol Biol Int, 42, pp.1007~1014 (1997)
- Gardner MJ, "Genome sequence of the human malaria parasite Plasmodium falciparum", Nature, 419, pp.498~511 (2002)
- Sullivan SKD, "Malaria: Drugs, Disease and Post-gemonic Biology" (2010), Springer
- Yang J, "Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked", Science, 275, pp.1129~1132 (1997)
- Srivastava IK, "Atovaquone, a broad spectrum antiparasitic drug, collapses mitochondrial membrane potential in a malarial parasite", J Biol Chem, 272, pp.3961~3966 (1997)